Drugs / IMUNOR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04710381 | Feb → Jun 2021 | COVID-19 | University Hospital Ostrava | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMUNOR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04710381 ↗ |
| Route | Oral | “Peroral Immunomodulation Treatment” NCT04710381 ↗ |